BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18977003)

  • 1. Multiple sclerosis: Cognition and saccadic eye movements.
    Fielding J; Kilpatrick T; Millist L; White O
    J Neurol Sci; 2009 Feb; 277(1-2):32-6. PubMed ID: 18977003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisaccade performance in patients with multiple sclerosis.
    Fielding J; Kilpatrick T; Millist L; White O
    Cortex; 2009; 45(7):900-3. PubMed ID: 19327763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of visually guided saccades in multiple sclerosis: Disruption to higher-order processes.
    Fielding J; Kilpatrick T; Millist L; White O
    Neuropsychologia; 2009 Jun; 47(7):1647-53. PubMed ID: 19397859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities in brain synchronization are correlated with cognitive impairment in multiple sclerosis.
    Arrondo G; Alegre M; Sepulcre J; Iriarte J; Artieda J; Villoslada P
    Mult Scler; 2009 Apr; 15(4):509-16. PubMed ID: 19282416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
    Strober L; Englert J; Munschauer F; Weinstock-Guttman B; Rao S; Benedict RH
    Mult Scler; 2009 Sep; 15(9):1077-84. PubMed ID: 19556311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters.
    Denney DR; Lynch SG; Parmenter BA
    J Neurol Sci; 2008 Apr; 267(1-2):129-36. PubMed ID: 17976653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study.
    Ukkonen M; Vahvelainen T; Hämäläinen P; Dastidar P; Elovaara I
    Mult Scler; 2009 Sep; 15(9):1055-61. PubMed ID: 19556313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological testing and event-related potentials in the assessment of cognitive performance in the patients with multiple sclerosis--a pilot study.
    Pokryszko-Dragan A; Zagrajek M; Slotwinski K; Gruszka E; Bilinska M; Podemski R
    Clin Neurol Neurosurg; 2009 Jul; 111(6):503-6. PubMed ID: 19233546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Information processing efficiency in patients with multiple sclerosis.
    Archibald CJ; Fisk JD
    J Clin Exp Neuropsychol; 2000 Oct; 22(5):686-701. PubMed ID: 11094403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Memory and executive functions in multiple sclerosis: preliminary findings with a cognitive battery].
    Marié RM; Defer GL
    Rev Neurol (Paris); 2001 Apr; 157(4):402-8. PubMed ID: 11398012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating functional decline in patients with Multiple Sclerosis.
    Rosenblum S; Tamar Weiss PL
    Res Dev Disabil; 2010; 31(2):577-86. PubMed ID: 20047816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Multiple Sclerosis Neuropsychological Screening Questionnaire in Argentina.
    Vanotti S; Benedict RH; Acion L; Cáceres F;
    Mult Scler; 2009 Feb; 15(2):244-50. PubMed ID: 18845653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verbal fluency deficits in multiple sclerosis.
    Henry JD; Beatty WW
    Neuropsychologia; 2006; 44(7):1166-74. PubMed ID: 16293271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment in three subtypes of multiple sclerosis.
    Denney DR; Sworowski LA; Lynch SG
    Arch Clin Neuropsychol; 2005 Dec; 20(8):967-81. PubMed ID: 15961271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease progression in multiple sclerosis: combining physicians' and patients' perspectives?
    Kragt JJ; Nielsen JM; van der Linden FA; Polman CH; Uitdehaag BM
    Mult Scler; 2011 Feb; 17(2):234-40. PubMed ID: 20978037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive deficits in multiple sclerosis patients with cerebellar symptoms.
    Valentino P; Cerasa A; Chiriaco C; Nisticò R; Pirritano D; Gioia M; Lanza P; Canino M; Del Giudice F; Gallo O; Condino F; Torchia G; Quattrone A
    Mult Scler; 2009 Jul; 15(7):854-9. PubMed ID: 19542264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.